Arch Therapeutics Inc (ARTH)

[GhostMOMENTUM]

I believe they'll wait until AC5 is launched in EU and in the US. The value here will exponentially increase as more happens (product launch - sales, FDA clearance, etc). I presume we're a couple years away from a buyout. I'm confident one will happen, by a large medical device company. JNJ makes the most sense to me still. I also think $1B is too low. Sounds nice right now but in a couple years I think we'll be thinking of a bigger number.